1. OP0307 Treatment of baff transgenic mice with ANTI-TNF: monoclonal ANTI-TNF are associated with a higher risk of lymphoma than etanercept. (15th June 2017) Authors: Nocturne, G; Bineta, L; Boudaoud, S; Pascaud, J; Seror, R; Nicco, C; Chereau, C; Mackay, F; Vincent, F; Lazure, T; Ferlicot, S; Stimmer, L; Roulland, S; Krzysiek, R; Hacein-Bey, S; Batteux, F; Mariette, X Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P028 Treatment of BAFF transgenic mice with ANTI-TNF: monoclonal ANTI-TNF are associated with a higher risk of lymphoma than etanercept. (21st February 2018) Authors: Nocturne, G; Ly, B; Boudaoud, S; Bitoun, S; Paoletti, A; Seror, R; Nicco, C; Mackay, F; Vincent, F; Ferlicot, S; Stimmer, L; Roulland, S; krzysiek, R; Hacein Bey, S; Batteux, F; Mariette, X Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 1 Page Start: A25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P110 TOFACITINIB is associated with an impaired function of NK cells and a defective immunosurveillance against B-cell lymphomas. (21st February 2018) Authors: Nocturne, G; Pascaud, J; Ly, B; Tahmasebi, F; Boudaoud, S; Seror, R; Stimmer, L; Mariette, X Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 1 Page Start: A60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗